Long for a Longtime or until they make me an offer I cant' Refuse
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No point actually just noticed the changed and brought it to everyone's attention. Not sure what it means.
Notice how the old one said exploratory drug and the new states new ALZ drug.
More breadcrumbs?
Just like last year the first poster title gave too much info.
Not concerned at all..
First poster title has changed...
Old
New Exploratory Alzheimer’s Drug ANAVEX 2-73: Dose Dependent Clinical Cognitive Improvement Observed in Mini Mental State Examination (MMSE) and Other Cognitive Markers in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Patients
New
New Alzheimer’s Drug ANAVEX 2-73: A Phase 2a Study, Clinical Safety, Tolerability and Maximum Tolerated Dose finding in mild-to-moderate Alzheimer’s Patients
Let me ask you a question.. Wouldn't 273 be protected under the patent that was approved for the cancer indication? BTW I have no fear...but lots of hope.
Keep in mind the dweebs go both ways...
Falcon,
Great point. BP has spent millions of dollars on the wrong solution to the problem. Anavex the little train that could.
Iman as far as I can see you are right on....may all longs live long and prosper!!!
I am a bit disappointed but not surprised....we have many day traders who sold the news along with the MM's who scared retail to get their shares.... Just my opinion..
It did happen and will probably happen again.....got to get papa troll some info for his hit piece...
There will come a time when they get all the facts correct...reminds me of Rodney.."I can't get no respect!"
Positive article... hit the links
http://investorplace.com/2016/07/10-healthcare-innovations/4/#.V5AXibgrKUm
Weak...very weak!
Answer me this....Why would we be presenting bad data twice?
I still am....not over till it's over....at this point I am not overly concerned
I think the timing of this is very telling...
http://ih.advfn.com/p.php?pid=nmona&article=72004547
Isn't this all about supply and demand? Maybe they know the SEC is watching and are afraid to do that naked thing or am I being naive?
Could it be that the SEC is watching this time?
If I remember correctly didn't someone say she was associated with AXON.
That's the one and I agree she is not a babe...I wonder if they will stop her this time.
go to Anavex.com
First poster is on Sunday...I am sure the twitter babe will be there feeding the cabal...Last time they were able to spin the data. This time I hope the good doctor is ready for them.
I also expect a Papa Troll (AF) article... Hopefully our data nullifies his BS.
Keep in mind, on the last option ex they were protecting $5...
That's easy...when it drops below the 50 DMA, he disappears.
If that is the case that still leaves the Dementia Care Practice 7/25 3:15 to 3:30 spot open which actually makes more sense...ties into the second poster
Under Developing Topics Oral Session the times have always shown 6 15 minute spots from 4:15 to 5:45, the last of which has not been filled
Don't believe everything you read on the internet...
I would think they would have changed the times and eliminated the 5:30 to 5:45 slot
https://ep70.eventpilotadmin.com/web/planner.php?id=AAIC16lite
You stand corrected.
Not true still two open.
Dementia Care Practice 7/25 3:15 to 3:30
Developing topics 7/27 5:30 to 5:45
Papa Troll at again with more miss information
$AVXL More '2-73 flim flam. Presenting 31-week efficacy results at #AAIC16 when that’s not a pre-specified timepoint in ph2b study.
— Adam Feuerstein ✡️ (@adamfeuerstein) July 12, 2016
I agree..... I like to think the good doctor is setting up the shorts.
I am not sure if the late breaking oral presentation is dead.
Not sure if this was posted... positive
http://www.insiderfinancial.com/a-major-breakout-on-anavex-life-sciences-corp-nasdaqavxl/115917/
Based on your theory, you are assuming dilution or some other kind of funding to support on going trials. Very possible if data is great.
The only explanation I could come up with was that it was a Robo Blog... I sent an email to the editor asking for a retraction of this trash piece.
I believe with all the stuff that has happen sec, lawsuits and all the other BS, he has become more careful. I think the holding off on data release proves that point.
Maybe because he had no need to...